(Q35179925)

7 August 2017

title

Type 1 diabetes and interferon therapy: a nationwide survey in Japan (English)

1 reference

7 August 2017

0 references

1 reference

5

Hiroshi Ikegami

1 reference

7 August 2017

2

Eiji Kawasaki

1 reference

7 August 2017

3

Akihisa Imagawa

1 reference

7 August 2017

12

Toshiaki Hanafusa

1 reference

7 August 2017

11

Taro Maruyama

1 reference

7 August 2017

6

Yasuko Uchigata

1 reference

7 August 2017

Kan Nakamura

1

1 reference

7 August 2017

Takuya Awata

4

1 reference

7 August 2017

Tetsuro Kobayashi

7

1 reference

7 August 2017

Akira Shimada

8

1 reference

7 August 2017

Koji Nakanishi

9

1 reference

7 August 2017

Hideichi Makino

10

1 reference

7 August 2017

Research Committee on Type 1 Diabetes of the Japan Diabetes Society

13

1 reference

7 August 2017

language of work or name

English

0 references

publication date

20 July 2011

1 reference

7 August 2017

1 reference

7 August 2017

volume

34

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

2084-2089

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

7 August 2017

copyright license

start time

1 September 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Syndromes of ketosis-prone diabetes mellitus

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

13 July 2018

Type 1 diabetes in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Interferon-alpha and autoimmune thyroid disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Fulminant type 1 diabetes: a nationwide survey in Japan

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Polyethylene glycol-interferon: current status in hepatitis C virus therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Distinct clinical courses in type 1 diabetes mellitus induced by peg-interferon-alpha treatment for chronic hepatitis C.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease?

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161293

Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta

27 September 2018

1 reference

12 December 2020

Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice

1 reference

12 December 2020

Induction of type I diabetes by interferon-alpha in transgenic mice

1 reference

12 December 2020

Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia

1 reference

12 December 2020

Occurrence of IDDM during interferon therapy for chronic viral hepatitis

1 reference

12 December 2020

Interferon expression in the pancreases of patients with type I diabetes

1 reference

12 December 2020

Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening

1 reference

12 December 2020

Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC10-2274

1 reference

7 August 2017

1 reference

7 August 2017

1 reference